Literature DB >> 23439485

Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways.

A Chakraborty1, C Latapy2, J Xu1, S H Snyder3, J-M Beaulieu2.   

Abstract

Glycogen synthase kinase 3 (GSK3), a prominent enzyme in carbohydrate metabolism, also has a major role in brain function. It is physiologically regulated by the kinase Akt, which phosphorylates GSK3 to inhibit catalytic activity. Inositol hexakisphosphate-1 (IP6K1) generates the inositol pyrophosphate diphosphoinositol pentakisphosphate (IP7), which physiologically inhibits Akt leading to enhanced GSK3 activity. We report that IP6K1 binds and stimulates GSK3 enzymatic activity in a non-catalytic fashion. Physiological relevance is evident in the inhibition of GSK3 activity in the brains of IP6K1-deleted mice. Behavioral alterations of IP6K1 knockout mice resemble those of GSK3 mutants. Accordingly, modulation of IP6K1-GSK3β interaction may exert beneficial effects in psychiatric disorders involving GSK3.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23439485     DOI: 10.1038/mp.2013.21

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  79 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation.

Authors:  Pamela A Lochhead; Ross Kinstrie; Gary Sibbet; Teeara Rawjee; Nick Morrice; Vaughn Cleghon
Journal:  Mol Cell       Date:  2006-11-17       Impact factor: 17.970

3.  Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase.

Authors:  Seyun Kim; Sangwon F Kim; David Maag; Micah J Maxwell; Adam C Resnick; Krishna R Juluri; Anutosh Chakraborty; Michael A Koldobskiy; Seung Hun Cha; Roxanne Barrow; Adele M Snowman; Solomon H Snyder
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

Review 4.  Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.

Authors:  R R Girgis; J A Javitch; J A Lieberman
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

Review 5.  Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions.

Authors:  James L Megna; Thomas L Schwartz; Umar A Siddiqui; Mariela Herrera Rojas
Journal:  Ann Clin Psychiatry       Date:  2011-05       Impact factor: 1.567

6.  Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells.

Authors:  B R Sperber; S Leight; M Goedert; V M Lee
Journal:  Neurosci Lett       Date:  1995-09-08       Impact factor: 3.046

Review 7.  The role of GSK3 in Alzheimer disease.

Authors:  Félix Hernández; Elena Gómez de Barreda; Almudena Fuster-Matanzo; Paloma Goñi-Oliver; José J Lucas; Jesús Avila
Journal:  Brain Res Bull       Date:  2009-05-27       Impact factor: 4.077

8.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

Authors:  L M Luttrell; S S Ferguson; Y Daaka; W E Miller; S Maudsley; G J Della Rocca; F Lin; H Kawakatsu; K Owada; D K Luttrell; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

9.  Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis.

Authors:  Rashna Bhandari; Krishna R Juluri; Adam C Resnick; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

10.  Neurological functions of the masterswitch protein kinase - gsk-3.

Authors:  Oksana Kaidanovich-Beilin; Jean-Martin Beaulieu; Richard Scott Jope; James Robert Woodgett
Journal:  Front Mol Neurosci       Date:  2012-04-09       Impact factor: 5.639

View more
  22 in total

Review 1.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

2.  Synthesis and characterization of novel isoform-selective IP6K1 inhibitors.

Authors:  Michael M Wormald; Glen Ernst; Huijun Wei; James C Barrow
Journal:  Bioorg Med Chem Lett       Date:  2019-08-20       Impact factor: 2.823

3.  Adipocyte-specific deletion of Ip6k1 reduces diet-induced obesity by enhancing AMPK-mediated thermogenesis.

Authors:  Qingzhang Zhu; Sarbani Ghoshal; Ana Rodrigues; Su Gao; Alice Asterian; Theodore M Kamenecka; James C Barrow; Anutosh Chakraborty
Journal:  J Clin Invest       Date:  2016-10-04       Impact factor: 14.808

Review 4.  The inositol pyrophosphate pathway in health and diseases.

Authors:  Anutosh Chakraborty
Journal:  Biol Rev Camb Philos Soc       Date:  2017-12-27

5.  Inositol pyrophosphates inhibit synaptotagmin-dependent exocytosis.

Authors:  Tae-Sun Lee; Joo-Young Lee; Jae Won Kyung; Yoosoo Yang; Seung Ju Park; Seulgi Lee; Igor Pavlovic; Byoungjae Kong; Yong Seok Jho; Henning J Jessen; Dae-Hyuk Kweon; Yeon-Kyun Shin; Sung Hyun Kim; Tae-Young Yoon; Seyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-30       Impact factor: 11.205

6.  FXR1P is a GSK3β substrate regulating mood and emotion processing.

Authors:  Thomas Del'Guidice; Camille Latapy; Antonio Rampino; Jivan Khlghatyan; Morgane Lemasson; Barbara Gelao; Tiziana Quarto; Giuseppe Rizzo; Annie Barbeau; Claude Lamarre; Alessandro Bertolino; Giuseppe Blasi; Jean-Martin Beaulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

Review 7.  New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.

Authors:  J Alex Grizzell; Valentina Echeverria
Journal:  Neurochem Res       Date:  2014-06-27       Impact factor: 3.996

Review 8.  Pharmacological Manipulation of the Circadian Clock: A Possible Approach to the Management of Bipolar Disorder.

Authors:  Alessandra Porcu; Robert Gonzalez; Michael J McCarthy
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

9.  Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening.

Authors:  Gangling Liao; Wenjuan Ye; Tyler Heitmann; Glen Ernst; Michael DePasquale; Laiyi Xu; Michael Wormald; Xin Hu; Marc Ferrer; Robert K Harmel; Dorothea Fiedler; James Barrow; Huijun Wei
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-03

10.  Fungal Inositol Pyrophosphate IP7 Is Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity.

Authors:  Sophie Lev; Cecilia Li; Desmarini Desmarini; Adolfo Saiardi; Nicole L Fewings; Stephen D Schibeci; Raghwa Sharma; Tania C Sorrell; Julianne T Djordjevic
Journal:  mBio       Date:  2015-06-02       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.